It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.
about
Rh Immunoprophylaxis for Women With a Serologic Weak D PhenotypeMolecular characterization of three novel weak D type alleles with additional haplotype data on weak D Types 1.2 and 18.Impact on patient of the detection of weakly expressed RhD antigens in blood donorsFinancial implications of RHD genotyping of pregnant women with a serologic weak D phenotype.Molecular immunohaematology round table discussions at the AABB Annual Meeting, Anaheim 2015A model for integrating molecular-based testing in transfusion services.Anti-D Antibodies in Pregnant D Variant Antigen Carriers Initially Typed as RhD.Considerations of red blood cell molecular testing in transfusion medicine.Anti-D reagents should be chosen accordingly to the prevalence of D variants in the obstetric population.Diverse and novel RHD variants in Australian blood donors with a weak D phenotype: implication for transfusion management.The experience of extended blood group genotyping by next-generation sequencing (NGS): investigation of patients with sickle-cell disease.Pathology Consultation on Patients With a Large Rh Immune Globulin Dose Requirement.First trimester noninvasive fetal RHD genotyping using maternal dried blood spots.Serological weak D phenotypes: a review and guidance for interpreting the RhD blood type using the RHD genotype.Low incidence of D alloimmunization among patients with a serologic weak D phenotype after D+ transfusion.Red cell genotyping precision medicine: a conference summary.Molecular immunohaematology round table discussions at the AABB Annual Meeting, Philadelphia 2014.Transfusion strategy for weak D Type 4.0 based on RHD alleles and RH haplotypes in Tunisia.RHCE variants inherited with altered RHD alleles in Brazilian blood donors.Application of Multiplex Ligation-Dependent Probe Amplification Assay for Genotyping Major Blood Group Systems Including DEL Variants in the D-Negative Korean Population.Significantly enhanced testing sensitivities of automated ORTHO VISION analyzers detect weak D phenotypes.Genotyping by sequencing defines independent novel RHD variants for an antenatal patient and a blood donor.Anti-D in a mother, hemizygous for the variant RHD*DNB gene, associated with hemolytic disease of the fetus and newborn.RHD alleles among pregnant women with serologic discrepant weak D phenotypes from a multiethnic population and risk of alloimmunization.Strategies to identify candidates for D variant genotyping.First description of a D-CE-D hybrid gene on a weak D Type 2 molecular background.Partial D in an obstetrical patient presenting as a mixed field on Rh typing.Resolving variable maternal D typing using serology and genotyping in selected prenatal patients.Frequency and characterization of known and novel RHD variant alleles in 37 782 Dutch D-negative pregnant women.ABO, Rhesus, and Kell Antigens, Alleles, and Haplotypes in West Bengal, India.Rhesus blood group haplotype frequencies among blood donors in southwestern Uganda.Weak D Testing is not Required for D- Patients With C-E- Phenotype
P2860
Q26801177-905A600A-9521-4515-AB8E-538D3B176B2CQ31165995-FAA07A08-1F33-44E7-A931-C2B5745FADCAQ36387410-ECCD0C8F-2362-4F44-B1A4-9EF9E07643ECQ36539925-7685A05D-AD1D-49DE-9554-20D52A6DB5A7Q37417326-030721B4-CD65-41B4-8768-A9158CFA5E10Q37417329-186C430F-C10E-4F16-959C-9A119F07722DQ37508079-D77B3CEC-200A-4D1B-8010-36C1F18C32A3Q38586467-D9B469A7-6178-4454-BAE2-06E12157457AQ38699049-6C4C81A1-0C75-4DC9-A081-C0D5D57F6AB0Q38755114-8BB2DC1E-1BB8-4DE7-B48C-B4BA8B96EE55Q38839295-62AB942E-FE54-4BCF-8920-1BDD9EB5F74EQ38856695-E41CCBB3-465D-4F0E-B49E-048C2A0A9CB3Q39084118-3B17EBF4-797A-40D3-AA68-84F4AD53EA52Q39309164-D84278D2-1735-4284-8D53-13EC4B183259Q39613099-AF7CEBF1-B1CC-4ECC-9216-93F158011DBFQ42375642-DF21FD9A-A84A-43E0-B8B5-367918A63D66Q42396851-10BFC500-1CBF-420D-AB45-4F96315A6D1FQ46442270-F15A9C6E-6944-406D-8D3C-1EEAFB89DF41Q46860292-E0D21983-CBB7-4453-BF2C-3F7B14E3701EQ47160293-43890DB9-3986-4127-978D-CA61EDB7DFC9Q47718464-4646ACF0-A256-40E2-AF5F-72CE14B4E528Q48118793-0C4B4259-2410-471F-851D-3D730ACA260BQ48238444-A0EC9EA2-09FA-466E-836F-10C299CDF05CQ48323852-E3C51540-2C25-4A80-B5AD-BBD3EEA0CCC5Q50207755-1A71051B-5108-4019-B632-7AF08BF8C15AQ50217076-C91B02DE-4827-4693-996E-E1FAD3C35120Q50227045-8DD463C4-5A7E-44DC-BF4E-5BD802842225Q50585300-D0483026-7446-4072-B035-61CF069503A1Q54453899-005F4095-F6BA-4F5A-A77C-17E37B68BBFEQ55037480-8196ED7A-7BCC-48B0-84FA-9DBDCC2A22A0Q55299975-5718ED26-EC2F-482E-9105-5523E38C2875Q57212436-9AF01B69-0668-4043-9C45-691769A5BDF6
P2860
It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
It's time to phase in RHD geno ...... Resource Committee Work Group.
@ast
It's time to phase in RHD geno ...... Resource Committee Work Group.
@en
type
label
It's time to phase in RHD geno ...... Resource Committee Work Group.
@ast
It's time to phase in RHD geno ...... Resource Committee Work Group.
@en
prefLabel
It's time to phase in RHD geno ...... Resource Committee Work Group.
@ast
It's time to phase in RHD geno ...... Resource Committee Work Group.
@en
P2093
P2860
P356
P1433
P1476
It's time to phase in RHD geno ...... Resource Committee Work Group
@en
P2093
Clayton D Simon
College of American Pathologists Transfusion Medicine Resource Committee Work Group
Connie M Westhoff
John T Queenan
Louis Katz
Margaret A Keller
Meghan Delaney
Ralph R Vassallo
S Gerald Sandler
Susan T Johnson
P2860
P304
P356
10.1111/TRF.12941
P577
2014-12-01T00:00:00Z